Page 84 - Sohini Das

India's pharma market rebounds in April, clocks 51.5% sales growth

Low base of April 2020, pick-up in demand for Covid-19 drugs major contributors to growth

Access to foreign Covid-19 vaccine a long haul, say Indian companies

US pharmaceutical associations feel that the decision to support the patent waiver would weaken already-strained supply chains

Hospitals to reap the benefits of RBI's health care liquidity injection

While top hospital chains reported an average borrowing cost of 9.8% in H1FY21, loans under the special RBI liquidity window for the health care sector are expected to come at around 6%

RBI's Covid relief: Good move, but late, says health care industry

While some companies said they were open to borrowing, others felt their working capital cycle was comfortable

Hetero recalls a batch of its remdesivir brand Covifor after side effects

Some patients in Raigad district of Maharashtra developed side effects like fever and chills

Key Covid-19 bulk drugs see 180% price increase over four months

However, there is no shortage expected at the retail level anytime soon

Have got full advance for 110 mn doses, says Serum CEO Poonawalla

Poonawalla, who left for the UK recently, said in an interview that he was getting threatening calls from powerful people in India for delivering vaccine

Gujarat gets the lion's share of Covid vaccines on Day 1 of the new phase

Health ministry data shows a huge disparity in the doses that were given in just eleven states which could launch the drive on May 1 due to paucity of supply

Phase 3 of Covid vaccination in Maharashtra gets off to a slow start

Mumbai started vaccinations for everyone aged above 18 from around 2 pm at only five BMC-run centres, which had a target of 200 vaccinations per centre

Vax 3.0: Hospitals, states ready for a slow start for those above 18 years

Maharashtra, Gujarat and UP to begin vaccination today

Govt should have built safety stock of essential drugs: Kiran Mazumdar-Shaw

The Biocon founder and Executive Chairperson points out that drugs like Remdesivir should be allowed at home as an emergency step

Bharat Biotech follows SII, reduces Covaxin price to Rs 400 for states

Earlier, the Bharat Biotech vaccine was priced at Rs 600 a dose

Serum cuts Covishield price by 25% for states, no change for pvt hospitals

Bharat Biotech is yet to announce any change in prices of Covaxin

Spiralling demand, leakages and a flourishing black market for remdesivir

Artificial shortages and brazen hawking of the drug on the streets at 15x the normal price rule the day as the official machinery tries desparately to stamp out the parallel market

Roche seeking fast approval of antibody cocktail in India to treat Covid

Co says demand for tocilizumab may exceed supplies it can provide

Return unused Covid-19 vaccine stock, govt tells private hospitals

Leading facilities in Mumbai, Delhi, Bengaluru have got communication in this regard

After states' objection, Centre asks vaccine manufacturers to lower prices

SII and Bharat Biotech had announced prices for state government procurement and for institutional sale to private hospitals

Centre clears the air on procurement of Covishield vaccine for states

Vaccination for those aged above 18 years could see a slow start in May

Bharat Biotech's Krishna Ella wants maximum price for its vaccine

Says the company would like to recover the costs incurred in clinical trials, and other things and reinvest the money into R&D to be ready for future pandemics

India could get its fourth vaccine by August, says NITI Aayog's V K Paul

Hyderabad-based Biological E's candidate has completed its phase one and two trials and is about to enter stage three